Skip to main content

English
Español

Company
- Overview
- Strategy
- Team
Epigenetics
- Epigenetics
- LSD1
Programs
Patients
- Clinical Trials
Investors
News & Events
- Press releases
- Events
Contact

Search

News & Events

Breadcrumb

Home
News & Events
Events

Events

Keyword

Year

11 December 2024

Video: Edison Group - executive interview with our CEO
12 November 2024

Video: Watch an interview with our CEO at BIO-Europe
14 October 2024

Video: Oryzon CNS corporate presentation at the Sachs Annual Biotech in Europe Forum
1 October 2024

Oryzon Webcast to Discuss FDA Feedback on End-of-Phase II Meeting and Plans for PORTICO-2 Phase III Trial with vafidemstat in Borderline Personality Disorder
25-26 September 2024

Sachs Annual Biotech in Europe Forum 2024

Mövenpick Hotel Basel

Basel

Switzerland
21-24 September 2024

European College of Neuropsychopharmacology (ECNP) congress 2024

Allianz MiCo convention center, Milan

MI

Italy
2-3 September 2024

German Fall Conference 2024

Le Meridien Hotel

Frankfurt

Germany
28 June 2024

Annual General Shareholders’ Meeting 2024

Madrid

Spain
17-20 June 2024

European Network to Cure ALS (ENCALS) 2024

Karolinska Institutet

Stockholm

Sweden
13-16 June 2024

European Hematology Association (EHA) 2024

IFEMA Recinto Ferial

Madrid

Spain

Pagination

First page «
Previous page ‹
Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Next page ›
Last page »

Email alerts

Subscribe and stay up to date with our latest events

Company

Overview
Strategy
Team

Epigenetics

Epigenetics
LSD1

Programs

Pipeline
Iadademstat
Vafidemstat
Collaborations
Publications

Patients

Clinical Trials

Investors

Share Information
Financial Information
CNMV Filings
Analyst Coverage
Corporate Governance
Corporate Social Responsibility

News & Events

Press releases
Events

Contact

Contact
Email Alerts
Join us

© Oryzon Genomics, S.A. - All Rights Reserved

Legal
Privacy Policy
Cookie Policy
Ethics Channel